Brief: Ecor1 Capital Reports 9.9% Stake In Galapagos NV As Of Aug 19
Aug 23 (Reuters) - Galapagos NV GLPG.AS :
* ECOR1 CAPITAL LLC REPORTS 9.9% STAKE IN GALAPAGOS NV AS OF
AUG
19 - SEC FILING
* ECOR1 CAPITAL LLC SAYS BELIEVES GALAPAGOS NV'S SECURITIES
ARE
DEEPLY "UNDERVALUED"
* ECOR1 CAPITAL LLC - INTENDS TO COMMUNICATE WITH GALAPAGOS’
MANAGEMENT, BOARD ABOUT VARIETY OF TOPICS RELATING TO CO'S
PERFORMANCE, BOARD COMPOSITION
Further company coverage: GLPG.AS
((reuters.briefs@thomsonreuters.com;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline